Phospho-ILK (S246) Antibody

What is Phospho-ILK (S246) and what is its significance in cellular signaling?

Phospho-ILK (S246) refers to the integrin-linked protein kinase when phosphorylated at serine residue 246. ILK functions as a scaffold protein that mediates protein-protein interactions during various cellular events including focal adhesion assembly, cell adhesion, and cell migration. It regulates integrin-mediated signal transduction by contributing to inside-out integrin activation . The phosphorylation of ILK at S246 represents a specific post-translational modification that affects its function and localization within the cell. ILK serves as a receptor-proximal protein kinase regulating integrin-mediated signal transduction and may act as a mediator of inside-out integrin signaling . This phosphorylation site is particularly significant as it is one of the convergence points of integrin- and growth factor-signaling pathways, potentially implicated in mediating cell architecture, adhesion to integrin substrates, and anchorage-dependent growth in epithelial cells .

How does phosphorylation at Ser246 affect ILK function and localization?

Phosphorylation of ILK at Ser246 has been shown to modulate its subcellular localization. Specifically, phosphorylation by PAK1 (p21-activated kinase 1) promotes the nuclear export of ILK . This post-translational modification appears to be a regulatory mechanism that determines where ILK functions within the cell. When phosphorylated at S246, ILK can participate in different protein complexes and cellular functions compared to its non-phosphorylated state. The ability to detect this specific phosphorylation state is critical for understanding the dynamic regulation of ILK in different cellular contexts and signaling environments .

What is the role of ILK in forming protein complexes?

ILK recruits PARVA and LIMS1/PITCH to form the heterotrimeric IPP (ILK-PINCH-PARVIN) complex, which binds to F-actin via the C-terminal tail of LIMS1 and the N-terminal region of PARVA . This interaction promotes F-actin filament bundling, a process required to generate force for actin cytoskeleton reorganization and subsequent dynamic cell adhesion events . The formation of this complex is essential for focal adhesion assembly and signaling. The phosphorylation status of ILK at S246 may influence the stability, composition, or function of these protein complexes, making detection of this phosphorylation site particularly valuable for studies focusing on cytoskeletal dynamics and cell-matrix interactions.

What are the optimal conditions for using phospho-ILK (S246) antibody in immunohistochemistry?

For optimal immunohistochemistry (IHC) results with phospho-ILK (S246) antibody, researchers should consider the following protocol:

• Use formalin/PFA-fixed paraffin-embedded sections of tissue samples.

• Apply the antibody at a dilution range of 1:50-1:300, with most manufacturers recommending 1:100-1:300 as an optimal starting range .

• Include appropriate controls, including tissue samples where the antibody is preincubated with a blocking peptide to confirm specificity of staining .

• Perform antigen retrieval if necessary, though specific protocols may vary depending on the tissue type.

• Optimize incubation time and temperature based on preliminary experiments.

Immunohistochemical staining of human brain tissue has been successfully performed with this antibody, demonstrating specific detection of phosphorylated ILK at S246 . The specificity is confirmed by the absence of staining when the antibody is preincubated with a blocking peptide .

How can I validate the specificity of a phospho-ILK (S246) antibody in my experiments?

Validating the specificity of phospho-ILK (S246) antibody is crucial for reliable experimental results. Consider implementing these validation strategies:

• Blocking peptide experiments: Compare staining with and without preincubation of the antibody with the phospho-specific blocking peptide. Specific staining should be eliminated or significantly reduced when the antibody is neutralized with the blocking peptide .

• Phosphatase treatment controls: Treat one set of samples with phosphatase to remove phosphate groups and compare with untreated samples. The signal should disappear or be significantly reduced in phosphatase-treated samples.

• Stimulation/inhibition experiments: Use compounds known to increase or decrease ILK phosphorylation at S246 (e.g., inhibitors of PAK1) and verify corresponding changes in antibody signal intensity.

• Genetic approaches: Use ILK knockout/knockdown cells or cells expressing phospho-deficient mutants (S246A) as negative controls.

• Cross-reactivity assessment: Test the antibody on samples from various species to confirm its reactivity matches the manufacturer's specifications (typically human, mouse, and rat) .

What are the recommended storage conditions and stability considerations for phospho-ILK (S246) antibody?

To maintain the optimal performance and longevity of phospho-ILK (S246) antibody, follow these storage recommendations:

• Store the antibody at -20°C for long-term storage (up to 1 year from the date of receipt) .

• For frequent use over short periods (up to one month), the antibody can be stored at 4°C .

• Avoid repeated freeze-thaw cycles as they can degrade antibody quality and reduce specificity and sensitivity .

• The antibody is typically supplied as a liquid in PBS containing 50% glycerol, 0.5% BSA, and 0.02% sodium azide, which helps maintain stability .

• Always centrifuge the antibody briefly before use to collect the liquid at the bottom of the vial.

Proper handling and storage will ensure consistent performance across experiments and maximize the usable lifespan of the antibody.

How does the phosphorylation status of ILK at Ser246 influence its interaction with binding partners?

The phosphorylation of ILK at Ser246 likely creates conformational changes that alter its interaction capabilities with various binding partners. While specific data on how S246 phosphorylation affects each interaction is limited in the search results, we can infer several mechanisms:

• The phosphorylation status may regulate the formation of the IPP (ILK-PINCH-PARVIN) complex, which is critical for focal adhesion assembly and signal transduction .

• Since phosphorylation by PAK1 promotes nuclear export of ILK , this suggests that S246 phosphorylation influences protein-protein interactions involved in nucleocytoplasmic shuttling.

• The phosphorylation may affect ILK's ability to bind to integrins and participate in integrin-mediated signaling pathways .

• Changes in phosphorylation could alter ILK's catalytic activity toward its substrates, including β-1 and β-3 integrin subunits .

Future research using techniques such as co-immunoprecipitation combined with phospho-specific antibodies would help elucidate the precise effects of S246 phosphorylation on ILK's interactome.

What are the technical challenges in studying temporal dynamics of ILK phosphorylation in live cells?

Investigating the real-time dynamics of ILK phosphorylation at S246 in live cells presents several technical challenges:

• Antibody accessibility: Phospho-specific antibodies cannot penetrate intact cell membranes, limiting their use to fixed cells or cell-free systems.

• Temporal resolution: The rapid and transient nature of phosphorylation events may be difficult to capture with traditional biochemical approaches. ILK is stimulated rapidly but transiently by both cell-fibronectin interactions and insulin in a PI3-K-dependent manner .

• Spatial resolution: Determining the subcellular localization of phosphorylated ILK requires sophisticated imaging techniques, especially when monitoring its nuclear export following PAK1-mediated phosphorylation .

• Signal-to-noise ratio: The specific detection of phospho-ILK against a background of non-phosphorylated protein requires highly specific reagents and optimized detection methods.

• Physiological relevance: Ensuring that observed phosphorylation events reflect normal cellular processes rather than artifacts of experimental manipulation.

To address these challenges, researchers might employ phospho-mimetic or phospho-deficient mutants of ILK, FRET-based biosensors, or advanced live-cell imaging techniques combined with selective inhibitors or stimulators of the relevant signaling pathways.

How can researchers differentiate between the kinase and scaffold functions of ILK in relation to S246 phosphorylation?

Distinguishing between ILK's kinase activity and its scaffold functions in the context of S246 phosphorylation requires systematic experimental approaches:

• Kinase-dead mutants: Generate ILK constructs with mutations in the kinase domain but with intact scaffold capabilities, then assess how S246 phosphorylation affects their function.

• Scaffold-disrupting mutations: Introduce mutations that specifically disrupt protein-protein interactions without affecting kinase activity, and examine the impact of S246 phosphorylation.

• Selective inhibitors: Use compounds that specifically target either the kinase activity or scaffold functions of ILK.

• Domain-specific antibodies: Employ antibodies that recognize different functional domains of ILK in combination with phospho-S246 antibodies.

• Functional readouts: Measure distinct endpoints associated with either kinase activity (e.g., phosphorylation of downstream targets) or scaffold functions (e.g., formation of multiprotein complexes).

By systematically manipulating each function while monitoring S246 phosphorylation status, researchers can delineate the relationship between this specific phosphorylation event and ILK's dual roles in cellular signaling.

How should variations in phospho-ILK (S246) staining intensity be interpreted across different cell types?

When analyzing variations in phospho-ILK (S246) staining intensity across different cell types, consider these factors:

• Baseline phosphorylation levels: Different cell types may have varying basal levels of ILK phosphorylation at S246 due to differences in upstream signaling pathways, particularly PI3K activity and integrin engagement .

• Kinase/phosphatase balance: Cell type-specific expression of PAK1 (which phosphorylates ILK) or relevant phosphatases will affect the steady-state levels of phospho-ILK (S246).

• Subcellular localization: Examine not just the intensity but also the subcellular distribution of staining. Since S246 phosphorylation affects nuclear export , the nuclear/cytoplasmic ratio of staining may be informative.

• Functional context: Interpret staining patterns in the context of known cell type-specific functions of ILK, particularly in relation to cell adhesion, migration, and cytoskeletal organization.

• Technical considerations: Standardize staining protocols across samples and include appropriate positive and negative controls to ensure that variations represent biological differences rather than technical artifacts.

Quantitative analysis using digital image processing can help objectively measure differences in staining intensity and provide more reliable comparisons across cell types.

What could explain discrepancies between phospho-ILK (S246) detection in western blot versus immunohistochemistry?

Discrepancies between western blot and immunohistochemistry results for phospho-ILK (S246) may arise from several methodological differences:

• Sample preparation: Western blotting involves tissue/cell lysis and protein denaturation, which may affect phospho-epitope integrity differently than the fixation and processing methods used for IHC.

• Epitope accessibility: In IHC, the three-dimensional structure of the tissue may limit antibody access to certain epitopes, while western blotting exposes denatured proteins more uniformly.

• Fixation effects: Different fixatives used in IHC can differentially preserve or mask phospho-epitopes. The recommended dilution for phospho-ILK (S246) antibody in IHC (1:50-1:300) differs from what might be optimal for western blotting .

• Sensitivity thresholds: Western blotting may have different detection thresholds compared to IHC, potentially leading to false negatives in one method but not the other.

• Specificity variations: The antibody may exhibit different specificity characteristics in the two methods, potentially recognizing additional epitopes or being blocked by interfering proteins in one context but not the other.

When encountering such discrepancies, consider verifying results with alternative detection methods or using different antibody clones that recognize the same phosphorylation site.

How can quantitative assessment of ILK phosphorylation changes be performed reliably?

For reliable quantitative assessment of changes in ILK phosphorylation at S246, implement these methodological approaches:

• Normalization strategies:

  • For western blotting: Normalize phospho-ILK signal to total ILK protein rather than housekeeping proteins.

  • For IHC/IF: Use ratio of phospho-ILK to total ILK staining in consecutive sections or dual staining approaches.

• Technical replicates: Perform multiple experimental replicates (minimum of three) to account for technical variability.

• Standardized conditions: Maintain consistent experimental conditions including cell density, stimulation timing, and reagent concentrations.

• Dynamic range verification: Ensure that detection methods operate within the linear range of the assay, avoiding signal saturation.

• Complementary approaches: Combine multiple techniques (e.g., western blotting, ELISA, and immunofluorescence) to cross-validate findings.

• Phosphorylation kinetics: When studying response to stimuli, perform time-course experiments to capture the potentially transient nature of ILK phosphorylation, which has been described as rapid but transient in response to fibronectin interactions and insulin .

• Statistical analysis: Apply appropriate statistical tests to determine the significance of observed changes, considering both biological and technical variability.